Home Zacks Investment Research Lowers Discovery Laboratories, Inc. (DSCO) to Sell
 

Keywords :   


Zacks Investment Research Lowers Discovery Laboratories, Inc. (DSCO) to Sell

2015-12-29 06:13:10| Biotech - Topix.net

According to Zacks, "Discovery Laboratories, Inc., formerly known as Ansan Pharmaceuticals, Inc., is a development-stage pharmaceutical company that focuses on developing compounds to treat respiratory diseases that affect the ability of the lungs to absorb oxygen. It is initially developing its lead product candidate, Surfaxin, for use by newborn infants to treat two respiratory conditions in critical care units of hospitals.

Tags: research sell investment discovery

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.06Disruption as airline pilots begin industrial action
26.06Atlantic Tropical Weather Outlook
26.06Eastern North Pacific Tropical Weather Outlook
26.06Now is not the time for African swine fever fatigue
26.06Ex-BHS director must pay 50m over firm's collapse
26.06WEG Mexico Obtains Quality Certificate from QUALICOAT
26.06Pork producers lead coalition against sprinkler mandate
26.06Cool Roof Coatings Market to Reach US$9.2B by 2030: Fairfield
More »